🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma
NCT07432022Combination Therapy, Aggressive B-Cell Non-Hodgkin Lymphoma, EMB07, phaseI/II
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2
115
Beijing
2026-04-01
Active, closed
IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT07473960Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
198
Beijing
2026-04-01
By invitation
Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative Surgery for Submucosal Tumor at the Gastroesophageal Junction
NCT07550582Submucosal Tumor of Gastrointestinal Tract, Gastrointestinal Stromal Tumor (GIST)
Peking University People's Hospital
Phase 2
40
Beijing
2026-04-01
Not yet open
A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer
NCT07294339Acupuncture Treatment, Hormone Receptor-Positive Breast Cancer, Hot Flashes
Peking University People's Hospital
Not applicable
60
Beijing
2026-04-01
Recruiting
A Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District
NCT07804420Hypertension
Peking University
Not applicable
500
Beijing
2026-04-01
Not yet open
Anesthesia Maintenance With Target-controlled Infusion of Propofol and Remifentanil at Fixed Ratio
NCT07479719Elderly, Surgery, Depth of Anesthesia, Total Intravenous Anesthesia
Peking University First Hospital
Phase 4
200
Beijing
2026-04
Not yet open
Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial
NCT07020559Diabetic Wounds, Platelet Rich Plasma, Allogeneic Blood Transfusions, Renal Dysfunction
Peking University Third Hospital
Phase 4
56
Beijing
2026-04
Not yet open
Safety and Efficacy of CT0494BCP in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma
NCT07538856Gastric, Gastric / Gastroesophageal Junction Adenocarcinoma
Beijing GoBroad Hospital
Observational
50
Beijing
2026-04
Not yet open
Burden-Evaluated Active Therapy for AF Using Continuous Wearables BEAT-AF Trial
NCT07512037Atrial Fibrillation (AF), Digital Health Intervention, Wearable Monitoring
Navy General Hospital, Beijing
Not applicable
3,194
Beijing
2026-04
Not yet open
Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients
NCT07523334Elderly, Noncardiac Surgery, Delayed Neurocognitive Recovery, Postoperative Delirium
Peking University First Hospital
Phase 4
120
Beijing, Tanjing
2026-04
Not yet open
Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
NCT07559032Invasive Fungal Disease
Peking University People's Hospital
Not applicable
15
Beijing
2026-04
Not yet open
Dexmedetomidine-esketamine Combination and Chronic Postsurgical Pain After Spinal Surgery
NCT07525999Spinal Surgery, Pain Intensity, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
274
Beijing
2026-04
Not yet open
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of RC010 Inhalation Powder in Healthy Participants
NCT07528703IPF
Nanjing Reju Therapeutics Co., Ltd
Phase 1
42
Beijing
2026-04
Not yet open
Ventilation-Perfusion Discrepancy Index Versus Conventional Anatomic-Physiologic Assessment for Target Lung Lobe Selection in Endobronchial Valve Placement: A Multicenter, Randomised Controlled Trial
NCT07403617Emphysema
China-Japan Friendship Hospital
Not applicable
285
Beijing
2026-04
Not yet open
Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study
NCT07582146Axial Spondyloarthritis, Axial Spondyloarthritis, Non-Radiographic, Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
Chinese PLA General Hospital
Phase 4
150
Beijing
2026-04
Not yet open
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.
NCT07543224Plaque Psoriasis Subjects
Reistone Biopharma Company Limited
Phase 3
600
Beijing
2026-04
Recruiting
NK Cell Therapy for Malignant Solid Brain Tumors
NCT07552233Malignant Solid Brain Tumors, Glioblastoma (GBM), Glioblastoma Multiforme (GBM), Brain Metastasis
Peking University Third Hospital
Not applicable
27
Beijing, Qinhuangdao, Zhengzhou
2026-04
Not yet open
Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI
NCT07511231Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Beijing Anzhen Hospital
Observational
1,800
Beijing
2026-04
Not yet open
Chronic Kidney Disease and Metabolic Disorders in the Elderly
NCT07494526Chronic Kidney Diease, Diabetes Mellitus, Hypertension, Hyperlipidemia
Chinese PLA General Hospital
Observational
100,000
Beijing
2026-04
Not yet open
Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
NCT07481903Psychoneurological Symptom Cluster(Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline), Pain, Insomnia, Anxiety
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Not applicable
228
Beijing, Nanjing, Qingdao, Tianjin
2026-04
Not yet open
Study on the Drug Interaction Between Buagafuran and Voriconazole
NCT07457203Drug Drug Interaction (DDI)
Beijing Union Pharmaceutical Factory Ltd
Phase 1
18
Beijing
2026-04
Not yet open
Bachmann Bundle Pacing for Prevention of New-Onset Atrial Fibrillation in Patients With Heart Failure
NCT07547449Heart Failure, Atrial Fibrillation (AF), Cardiac Insufficiency
Fu Wai Hospital, Beijing, China
Not applicable
140
Beijing
2026-04
Not yet open
A Multicenter, RAndomIzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With AI-assisted Robotic guidanCe for Hemorrhagic Stroke
NCT06459427Brain Stem Hemorrhage, Robotic Surgical Procedures
Yanbing Yu
Not applicable
142
Beijing, Shijiazhuang
2026-04
Not yet open
Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in Women
NCT07507851Urinary Tract Infections, Recurrent, Electroacupuncture, Randomized Controlled Trial (RCT)
Yanjun Zhang, Baoyan Liu
Not applicable
312
Beijing, Tianjin
2026-04
Not yet open
Dexmedetomidine-esketamine Combination and Moderate-to-severe Pain After Spinal Surgery
NCT07523321Spinal Surgery, Pain Intensity, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
274
Beijing
2026-04
Not yet open
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
NCT07482319Advanced Solid Tumors
Beijing Geekgene Technology Co., LTD
Phase 1
15
Beijing
2026-04
Not yet open
Ultrasounic Elastography-guided Pleural Biopsy Followed by As-needed Medical Thoracoscopic Pleural Biopsy Versus Immediate Medical Thoracoscopic Pleural Biopsy for the Diagnosis of Pleural Effusion
NCT07419620Pleural Effusion Disorder
China-Japan Friendship Hospital
Not applicable
420
Beijing
2026-04
Recruiting
Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas
NCT07407803Plexiform Neurofibroma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
177
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Nanning, Guiyang
2026-03-31
Not yet open
Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorrhage
NCT07471256Intracerebral Hemorrhage Lobar
Beijing Tiantan Hospital
Phase 3
636
Beijing
2026-03-31
Not yet open
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
NCT07396870Schizophrenia
Luye Pharma Group Ltd.
Phase 2
160
Beijing
2026-03-31
Not yet open
LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
NCT07391566Metastatic Colorectal Cancer (mCRC)
Luye Pharma Group Ltd.
Phase 1/2
99
Beijing
2026-03-31
Recruiting
A Clinical Study to Evaluate SM17 for Atopic Dermatitis
NCT07445919Atopic Dermatitis
SinoMab BioScience Ltd
Phase 2
200
Beijing
2026-03-31
Not yet open
FXS6837 for the Treatment of IgAN Patients
NCT07502638IgAN
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
60
Beijing
2026-03-31
Recruiting
A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
NCT07465263Heterozygous Familial Hypercholesterolemia (HeFH)
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
135
Beijing
2026-03-31
Recruiting
A Study of E6742 in Participants With Systemic Lupus Erythematosus
NCT07515014Systemic Lupus Erythematosus
Eisai Co., Ltd.
Phase 2
256
Bengbu, Beijing, Chongqing, Guangzhou, Shantou, Nanning, Guiyang, Luoyang
2026-03-31
Recruiting
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
NCT07466238Biliary Tract Cancer (BTC)
Peking University
Not applicable
40
Beijing
2026-03-31
Not yet open
A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy
NCT07421284Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
900
Beijing
2026-03-31
Active, closed
Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
NCT07651475R/R AML
Liping Dou
Phase 2
32
Beijing
2026-03-31
Not yet open
Advancing Reperfusion Therapy for Ischemic Stroke: Direct Transfer to Angiography Suite for Patients With Suspected Large Vessel Occlusion
NCT07460713Ischemic Stroke, Large Vessel Occlusion
Beijing Tiantan Hospital
Not applicable
568
Beijing
2026-03-31
Not yet open
A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis
NCT07393451Lupus Nephritis
Simcere Pharmaceutical Co., Ltd
Phase 2
60
Beijing
2026-03-31
Recruiting
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
NCT07329322Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
30
Beijing
2026-03-30
Recruiting
Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications?
NCT07322705Femoroacetabular Impingement Syndrome
ChunBao Li
Not applicable
270
Beijing, Shenzhen, Luoyang, Nanjing, Xi'an, Tai’an, Shanghai, Chengdu
2026-03-30
Recruiting
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
NCT07084519Breast Cancer, Breast Reconstruction, Radiation Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
506
Beijing
2026-03-27
Not yet open
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
NCT07417306Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
912
Beijing
2026-03-27
Not yet open
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapy
NCT07501832Obstructive Sleep Apnea (OSA)
Gan & Lee Pharmaceuticals.
Phase 3
140
Beijing
2026-03-27
Not yet open
Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy
NCT07489157Hypoxemia
Chinese PLA General Hospital
Not applicable
460
Beijing
2026-03-27
Recruiting
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
NCT07405151Oesophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC
Phase 1/2
60
Hefei, Beijing, Xiamen, Zhengzhou, Xuzhou, Jinan, Hangzhou
2026-03-27
Recruiting
A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity
NCT07478822Upper Limb Spasticity
Chongqing Claruvis Pharmaceutical Co., Ltd.
Phase 3
300
Beijing, Chengdu, Guangdong, Guangzhou, Hefei, Huai'an, Kaifeng, Kunming
2026-03-27
Recruiting
To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
NCT07447986Systemic Lupus Erythematosus (SLE)
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
120
Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou, Shenzhen, Guilin, Nanning
2026-03-26
Recruiting
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
NCT07493265Narcolepsy
Eisai Inc.
Phase 2
64
Beijing, Changchun, Guangdong, Guangzhou, Jinan, Nanchang, Shanghai, Zhengzhou
2026-03-26
Recruiting
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
NCT07388680Radiation-induced Lung Injury, Immune-related Pneumonia
Beijing Continent Pharmaceutical Co, Ltd.
Phase 2/3
298
Hefei, Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou, Maoming, Shenzhen
2026-03-26
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals
Phase 2
32
Beijing, Shanghai
2026-03-26
Active, closed
Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection
NCT07826585Advanced Solid Tumors
Corregene Biotechnology Co., Ltd
Phase 1
6
Beijing
2026-03-26
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351Advanced Renal Cell Carcinoma (RCC)
Bristol-Myers Squibb
Phase 1/2
474
Beijing, Guangzhou, Tianjin, Harbin, Changsha Shi, Nanjing, Shanghai Shi
2026-03-26
Recruiting
Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery
NCT07479446PONV, Cerebellopontine Angle Tumor, Microvascular Decompression Surgery, Postoperative Analgesia
Xuanwu Hospital, Beijing
Not applicable
174
Beijing
2026-03-25
Recruiting
A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer
NCT07450976Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
151
Beijing, Shanghai
2026-03-25
Not yet open
A Study of BEN301 Injection in the Treatment of Autoimmune Diseases
NCT07502859SSC RA SS IIM
Beijing Boren Hospital
Phase EARLY_PHASE1
24
Beijing, Shanghai
2026-03-25
Recruiting
A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy
NCT07487896Advanced Esophageal Squamous Cell Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
440
Anqing, Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou
2026-03-24
Recruiting
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
NCT07372729Prehypertension, Borderline Dyslipidemia, Overweight , Obesity, Prediabetes
Beijing Anzhen Hospital
Not applicable
1,400
Beijing, Cangzhou, Yuhuan
2026-03-24
Recruiting
Lung EIT Image Guide Ventilation in ARDS
NCT07309783ARDS (Acute Respiratory Distress Syndrome)
Peking Union Medical College Hospital
Not applicable
574
Beijing
2026-03-24
Recruiting
A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain
NCT07377721Diabetic Peripheral Neuropathic Pain
Shandong Suncadia Medicine Co., Ltd.
Phase 1
168
Beijing, Chongqing
2026-03-24
Recruiting
The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders
NCT07458100Emotional Disorders, Depressive Disorder, Anxiety Disorders, Obsessive-Compulsive Disorder
Peking University
Not applicable
464
Beijing
2026-03-23
Recruiting
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
NCT07293260Cardiovascular Disease
Amgen
Phase 3
406
Beijing, Zhengzhou, Changsha, Nanjing, Yinchuan, Xi'an, Jinan
2026-03-23
Recruiting
Safety and Efficacy of the Extracorporeal Ventricular Assist System in Car Diogenic Shock: A Prospective, Multicenter , Single-Arm Study
NCT07769528Cardiogenic Shock
China National Center for Cardiovascular Diseases
Not applicable
40
Beijing
2026-03-23
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT07351058Obesity or Overweight, Type 2 Diabetes Mellitus
Hoffmann-La Roche
Phase 3
1,600
Cangzhou, Kaifeng, Xuzhou, Zhenjiang, Xianyang, Jinan, Ningbo, Beijing
2026-03-23
Recruiting
Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System
NCT07501234Mitral Regurgitation (MR)
Mitrassist Lifesciences Limited Co., Ltd.
Not applicable
5
Beijing
2026-03-23
Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
NCT07355296Proteinuric Kidney Diseases
Boehringer Ingelheim
Phase 2
132
Beijing, Chengdu, Guangzhou, Nanchang, Nanjing, Nanning, Shanghai, Sichuan
2026-03-23
Recruiting
Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS
NCT07490925ARDS (Moderate or Severe)
Beijing Chao Yang Hospital
Not applicable
180
Beijing
2026-03-23
Recruiting
Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation
NCT06872021ECMO
Beijing Anzhen Hospital
Not applicable
358
Beijing
2026-03-22
Not yet open
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis
NCT07465120Moderate to Severe Atopic Dermatitis
Dermavon Holdings Limited
Phase 2
160
Beijing, Fuzhou, Guangzhou, Shenzhen, Haikou, Shijiazhuang, Tangshan, Zhengzhou
2026-03-20
Recruiting
Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder
NCT07480525Depression - Major Depressive Disorder
Peking University
Not applicable
200
Beijing, Baoding, Shijiazhuang, Shenyang, Jinan
2026-03-20
Recruiting
Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML
NCT07500441Acute Myeloid Leukemia (AML)
Peking University People's Hospital
Observational
100
Beijing
2026-03-20
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
NCT07409428Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hutchmed
Phase 3
240
Shanghai, Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing
2026-03-20
Active, closed
Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation
NCT07490808Atrial Fibrillation (AF), Acute Kidney Injury
Beijing Anzhen Hospital
Not applicable
290
Beijing
2026-03-20
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
NCT07477626Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy
Sun Yat-sen University
Phase 3
372
Dongguan, Guangzhou, Zhanjiang, Zhengzhou, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-20
Recruiting
Effect of a Localized ICU AI Teaching Agent on Rotating ICU Residents
NCT07692035Cognitive Load and Task Performance in Rotating Residents
Peking Union Medical College Hospital
Not applicable
44
Beijing
2026-03-20
Recruiting
Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
NCT07398859Seasonal Allergic Rhinitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 2
300
Beijing, Chongqing, Baoding, Cangzhou, Langfang, Shijiazhuang, Zhangjiakou, Zhengzhou
2026-03-19
Recruiting
A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
NCT07412691Skin Diseases
BeOne Medicines
Phase 1
98
Beijing, Chongqing, Fuzhou, Shijiazhuang, Changsha, Suzhou, Shenyang, Shanghai
2026-03-19
Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
NCT07487883Non-Small Cell Lung Cancer, Malignant Neoplasm, Pulmonary Nodules, PET/CT
Peking University People's Hospital
Observational
80
Beijing
2026-03-18
Recruiting
A Study of MG2512 Injection in Participants With Advanced Solid Tumors
NCT07348653Advanced Solid Tumor
Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.
Phase 1
116
Beijing, Chengdu
2026-03-18
Recruiting
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
NCT07431827Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
400
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Hshijiazhuang, Wuhan, Changsha
2026-03-18
Recruiting
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
NCT06947473Refractory Lupus Nephritis, Systemic Sclerosis, Primary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital
Phase 1/2
45
Beijing
2026-03-18
Not yet open
Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia
NCT07453836Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
13
Beijing
2026-03-18
Recruiting
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
NCT07691307Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
Jiangsu Trulive Medical Co., Ltd
Not applicable
180
Beijing
2026-03-18
Recruiting
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
NCT07777861Primary Open-Angle Glaucoma, Optic Nerve Injury
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
Phase 2
90
Beijing, Guangzhou, Shantou, Changsha, Tianjin, Hangzhou, Wenzhou
2026-03-18
Not yet open
Efficacy and Safety Study of HS-10542 for IgA Nephropathy
NCT07474636IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 2
90
Beijing
2026-03-17
Recruiting
PregnAncy-Related Aortic DISsEction in China
NCT07672210Pregnancy Complication, Aortic Dissection, Marfan Syndrome, Loeys-Dietz Syndrome
DeltaHealth Hospital · Shanghai
Observational
500
Shanghai, Beijing, Guangzhou, Wuhan
2026-03-17
Recruiting
Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial
NCT07341932Stable Coronary Artery Disease CAD
Beijing Anzhen Hospital
Not applicable
1,312
Beijing, Chengdu, Ürümqi
2026-03-17
Recruiting
Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma
NCT07692152Anal Squamous Cell Carcinoma, Limited-stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
350
Beijing, Shenzhen
2026-03-17
Recruiting
Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
NCT07529782Multiple Myeloma and Other Plasma Cell Neoplasms
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
15
Beijing, Suzhou, Jinan, Tianjin, Hangzhou
2026-03-17
Recruiting
Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment
NCT07498478Breast Cancer
TransThera Sciences (Nanjing), Inc.
Phase 2
94
Guangzhou, Wuhan, Changsha, Nanjing, Jinan, Linyi, Hangzhou, Beijing
2026-03-17
Recruiting
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors
NCT07477743Advanced Solid Tumor Cancer
HC Biopharma Inc.
Phase 1
331
Beijing
2026-03-17
Not yet open
Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death
NCT07476456Sudden Cardiac Death
China National Center for Cardiovascular Diseases
Observational
421
Beijing
2026-03-16
Not yet open
A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
NCT07464119Diabetes Mellitus
Peking University First Hospital
Not applicable
30
Beijing
2026-03-16
Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
NCT07291076Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb
Phase 1/2
198
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Harbin, Nanyang
2026-03-16
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
NCT07361497Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 3
850
Beijing, Chongqing, Fuzhou, Shantou, Shenzhen, Zhengzhou, Jingzhou, Wuhan
2026-03-16
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
NCT07351045Obesity or Overweight
Hoffmann-La Roche
Phase 3
2,000
Zhenjiang, Xianyang, Jinan, Beijing, Changchun, Hefei, Herbin, Huizhou
2026-03-16
Not yet open
A Study of JSKN027 in Patients With Advanced Solid Tumors
NCT07391644Advanced Malignant Solid Tumor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1
250
Beijing
2026-03-15
Recruiting
The Effect of Oscillation and Lung Expansion (OLE) Therapy in Prolonged Mechanical Ventilated Patients With Atelectasis Evaluated in Multiple Methods
NCT07451405Atelectasis
Capital Medical University
Not applicable
60
Beijing
2026-03-15
Not yet open
Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Patellar Chondromalacia
NCT07423819Anterior Cruciate Ligament Injury, Patellofemoral Pain Syndrome
Peking University Third Hospital
Not applicable
160
Beijing
2026-03-15
Rows per page Showing 801–900 of 5484
Previous 7 8 9 10 11 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=9

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.